| 5BRO: reference: Therapeutic potential of intracerebroventricular replacement of modified human beta-hexosaminidase B for GM2 gangliosidosis., Matsuoka K, Tamura T, Tsuji D, Dohzono Y, Kitakaze K, Ohno K, Saito S, Sakuraba H, Itoh K, Mol Ther. 2011 Jun;19(6):1017-24. doi: 10.1038/mt.2011.27. Epub 2011 Apr 12. PMID: 21487393 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).